Germline variants in DNA repair genes are associated with young-onset head and neck cancer

Nenhuma Miniatura disponível

Data

2021-11-01

Autores

Cury, Sarah Santiloni [UNESP]
Miranda, Priscila Mayrink de
Marchi, Fabio Albuquerque
Canto, Luisa Matos do
Chulam, Thiago Celestino
Petersen, Annabeth Høgh
Aagaard, Mads M.
Pinto, Clóvis Antonio Lopes
Kowalski, Luiz Paulo
Rogatto, Silvia Regina

Título da Revista

ISSN da Revista

Título de Volume

Editor

Resumo

The genetic predisposition to head and neck carcinomas (HNSCC) and how the known risk factors (papillomavirus infection, alcohol, and tobacco consumption) contribute to the early-onset disease are barely explored. Although HNSCC at early onset is rare, its frequency is increasing in recent years. Germline and somatic variants were assessed to build a comprehensive genetic influence pattern in HNSCC predisposition and patient outcome. Whole-exome sequencing was performed in 45 oral and oropharynx carcinomas paired with normal samples of young adults (≤49 years). We found FANCG, CDKN2A, and TPP germline variants previously associated with HNSCC risk. At least one germline variant in DNA repair pathway genes was detected in 67% of cases. Germline and somatic variants (including copy number variations) in FAT1 gene were identified in 9 patients (20%) and 12 tumors (30%), respectively. Somatic variants were found in HNSCC associated genes, such as TP53, CDKN2A, and PIK3CA. To date, 55 of 521 cases from the large cohort of TCGA presented < 49 years old. A comparison between the somatic alterations of TCGA-HNSCC at early onset and our dataset revealed strong similarities. Protein-protein interaction analysis between somatic and germline altered genes revealed a central role of TP53. Altogether, germline alterations in DNA repair genes potentially contribute to an increased risk of developing HNSCC at early-onset, while FAT1 could impact the prognosis.

Descrição

Palavras-chave

Cancer predisposition, Early-onset cancer, Oral cavity carcinomas, Oropharynx carcinomas, Risk factors, Whole-exome sequencing

Como citar

Oral Oncology, v. 122.

Coleções